Application of nanomedicine in emergency medicine; Point-of-care testing and drug delivery in twenty - First century

DARU, Journal of Pharmaceutical Sciences

Volumn 20, Issue 1, 2012, Pages

  Pourmand, Ali ^a   Pourmand, Mohammad Reza ^b   Wang, Justin ^a   Shesser, Robert ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868123823     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-20-26     Document Type: Review

References (25)

1. Theres plenty of room at the bottom. Feynman RP, Eng Sci (Caltech) 1960 23 22 36
2. Drexeler KE, Nanosystems: Molecular Machinery, Manufacturing, and Computation 2006 http://www.e-drexler.com/d/06/00/ Nanosystems/toc.html. ISBN ISBN 0-471-57518-6.
3. National Nanotechnology Initiative, What it is and how it works 2011 Available at: http://www.nano.gov/. Accessed June 20, 2011.
4. Battery materials for ultrafast charging and discharging. Kang B, Ceder G, Nature 2009 458 190 193 10.1038/nature07853 19279634
5. Nanomedicines in action. Duncan R, Pharm J 2004 273 485 488 (Pubitemid 39378071)
6. New advances in nanomedicine: Diagnosis and preventive medicine. Wei C, Nagai T, Wei W, Nemoto T, Awais M, Niwa O, et al. Med Clin North Am 2007 91 871 879 10.1016/j.mcna.2007.05.002 17826107 (Pubitemid 47361205)
7. Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. Floriano PN, Christodoulides N, Miller CS, Ebersole JL, Spertus J, Rose BG, et al. Clin Chem 2009 55 1530 1338 10.1373/clinchem.2008.117713 19556448
8. Nano neurology and the four Ps of central nervous system regeneration: Preserve, permit, promote, plasticity. Ellis-Behnke R, Med Clin North Am 2007 91 937 962 10.1016/j.mcna.2007.04.005 17826112 (Pubitemid 47371019)
9. A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles. Zhao X, Hilliard LR, Mechery SJ, Wang Y, Bagwe RP, Jin S, et al. Proc Natl Acad Sci USA 2004 101 15027 15032 10.1073/pnas. 0404806101 15477593 (Pubitemid 39391712)
10. McRobbie DW, Moore EA, Graves MJ, Prince MR, MRI from Picture to Proton Cambridge: Cambridge University Press 2002 17 45
11. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Na HB, Lee JH, An K, Park YI, Park M, Lee IS, et al. Angew. Chem Int Ed Engl 2007 46 5397 5401 10.1002/anie.200604775 17357103 (Pubitemid 47067643)
12. Molecular and cellular imaging of atherosclerosis: Emerging applications. Jaffer FA, Libby P, Weissleder R, J Am Coll Cardiol 2006 47 1328 1338 10.1016/j.jacc.2006.01.029 16580517
13. Nanomedicine and Cardiovascular Disease. McCarthy JR, Curr Cardiovasc Imaging Ref 2010 3 42 49 10.1007/s12410-009-9002-3
14. Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques. Yu SS, Ortega RA, Reagan BW, McPherson JA, Sung HJ, Giorgio TD, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011 3 620 646 10.1002/wnan.158
15. Prevention of malathion-induced depletion of cardiac cells mitochondrial energy and free radical damage by a magnetic magnesium-carrying nanoparticle. Shafiee H, Mohammadi H, Rezayat SM, Hosseini A, Baeeri M, Hassani S, et al. Toxicol Mech Methods 2010 20 9 538 543 10.3109/15376516.2010.518173 20919798
16. Nanomedicine and drug delivery. Wei C, Wei W, Morris M, Kondo E, Gorbounov M, Tomalia DA, Med Clin North Am 2007 91 863 870 10.1016/j.mcna.2007. 05.005 17826106 (Pubitemid 47361208)
17. Recent advances in basic and clinical nanomedicine. Morrow KJ, Bawa R, Wei C, Med Clin North Am 2007 91 805 843 10.1016/j.mcna.2007.05.009 17826104 (Pubitemid 47364736)
18. Future approaches of nanomedicine in clinical science. Brewer M, Zhang T, Dong W, Rutherford M, Tian ZR, Med Clin North Am 2007 91 963 1016 10.1016/j.mcna.2007.05.006 17826113 (Pubitemid 47361209)
19. Heart disease and stroke statistics-2011 update. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Circulation 2011 123 18 e209 10.1161/CIR.0b013e3182009701 21160056
20. Rationale for a nanomedicine approach to thrombolytic therapy. Lanza GM, Marsh JN, Hu G, Scott MJ, Schmieder AH, Caruthers SD, et al. Stroke 2010 41 suppl 42 44
21. Nanotechnology crucial in fighting infectious disease. Morris K, Lancet Infect Dis 2009 9 215 10.1016/S1473-3099(09)70100-8 19378486
22. National estimates of severe sepsis in United States emergency departments. Wang HE, Shapiro NI, Angus DC, Yealy DM, Crit Care Med 2007 35 1928 1936 10.1097/01.CCM.0000277043.85378.C1 17581480 (Pubitemid 47220368)
23. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Crit Care Med 2008 36 296 327 10.1097/01.CCM.0000298158. 12101.41 18158437
24. Amelioration of experimental colitis by a novel nanoselenium-silymarin mixture. Miroliaee A, Esmaily H, Vaziri-Bami A, Baeeri M, Shahverdi AR, Abdollahi M, Toxicol Mech Methods 2011 21 3 200 208 10.3109/15376516.2010.547887 21247366
25. Benefit of magnesium-25 carrying porphyrinfullerene nanoparticles in experimental diabetic neuropathy. Hosseini A, Sharifzadeh M, Rezayat SM, Hassanzadeh G, Hassani S, Baeeri M, et al. Int J Nanomedicine 2010 5 517 523 20957114